Jeff Liter

Company: Luminary Therapeutics

Job title: CEO

Seminars:

Panel Discussion: Comparing Immune Cell Depletion & Immune Tolerance Therapies to Accelerate Safer, Efficacious Therapies 1:40 pm

Expand therapeutic approaches beyond B-cell depletion Highlight safety challenges with depletion in comparison to tolerance with Tregs Explore the long-term biological effects of B-cell depletion and immune reprogramming therapiesRead more

day: Conference Day One Pink Track P2

Expanding CAR-T Targets Beyond CD-19 to Enhance Treatment Efficacy Across Autoimmune Diseases 11:30 am

Evaluate CD-19’s strengths and limitations as the anchor target for CAR-T treatment of autoimmune diseases Explore novel targets to broaden the spectrum and complexity of treatable autoimmune diseases Evaluate available targeting options to pinpoint optimal targets for varying autoimmune and autoinflammatory diseasesRead more

day: Conference Day One Pink Track P1